USEF Rule Permits Use of Surpass

Effective Dec. 1, 2004, the United States Equestrian Federation (USEF) Equine Drugs and Medications Rule permits the therapeutic use of Surpass, a nonsteroidal anti-inflammatory product (NSAID) recently approved by the FDA for use in horses. This is a topical preparation of 1% diclofenac cream, from IDEXX Pharmaceuticals. (For more information on the FDA approval of Surpass, click

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners